Site icon OncologyTube

The sequencing of novel agents: Does it matter?

Earn CME: https://naccme.com/program/7314

In this presentation from the ‘Navigating the Evolving Therapeutic Landscape of CLL: Strategies for the Optimal Application of Emerging Agents and Combinations in Practice symposium, Dr. Peter Hillmen discusses whether the sequence of novel agents for CLL matters.

© 2018 Imedex, an HMP Company

Exit mobile version